Re: Third Eye, AHA, US Listing

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Third Eye, AHA, US Listing

in response to

Re: Third Eye, AHA, US Listing

Carman2

posted on Sep 19, 2019 10:44AM

Carman....Why are you asking the exact same question again after I already responded to you? Here's your answer again:

Top-line data availability is not required for a trial to be considered and given a late breaking clinical trial presentation. Perfect example.....Amarin's REDUCE-IT trial.

Amarin announced their AHA 2018 late breaker on September 12th, 2018 but didn't announce REDUCE-IT top-line until September 24, 2018.

Late breaking (and non-late breaking) presentations can be for stellar, so-so, or failed trials results. There are examples of each out there. If you don't believe me, go back through archives of past AHA, ADA, ESC, EASD, and ACC conferences.